What A New Antiviral Drug Could Mean For The Future Of COVID

Pien Huang, an NPR health reporter focusing on COVID-19 developments, shares her insights on a newly recommended antiviral drug for COVID-19. She discusses the FDA's expected decision and how this drug could transform treatment options. The conversation also delves into the implications for pandemic management, comparing this new therapy to existing treatments. Huang emphasizes the crucial need for accessible antiviral treatments, particularly in under-resourced areas, highlighting potential licensing agreements to facilitate affordable options.